Symptoms often begin to emerge when levels fall below 3.0 mmol/L, but this threshold is not absolute some individuals, particularly those with underlying heart disease, those taking digoxin, older adults, or those experiencing a rapid fall in potassium, may develop symptoms or ECG changes at levels between 3.0 and 3.5 mmol/L
No regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved either component peptide, or the blend formulation, as a drug for human or veterinary use
Related products More catalog records from the same research category
We prioritize speed and reliability to keep your project timelines on track.
It typically contains a blend of ingredients known as MIC: Methionine, Inositol, and Choline
Great product great service